.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Harvard Business School
Fuji
Colorcon
Novartis
Chinese Patent Office
Cantor Fitzgerald
Teva
Cipla
Federal Trade Commission

Generated: November 19, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050767

« Back to Dashboard
NDA 050767 describes CLEOCIN, which is a drug marketed by Pharmacia And Upjohn and is included in fourteen NDAs. It is available from three suppliers. There is one patent protecting this drug. Additional details are available on the CLEOCIN profile page.

The generic ingredient in CLEOCIN is clindamycin phosphate. There are fifty-three drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the clindamycin phosphate profile page.

Summary for 050767

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Pharmacology for NDA: 050767

Ingredient-typeLincosamides
Physiological EffectDecreased Sebaceous Gland Activity

Suppliers and Packaging for NDA: 050767

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLEOCIN
clindamycin phosphate
SUPPOSITORY;VAGINAL 050767 NDA Pharmacia and Upjohn Company LLC 0009-7667 0009-7667-01 1 BLISTER PACK in 1 CARTON (0009-7667-01) > 3 SUPPOSITORY in 1 BLISTER PACK
CLEOCIN
clindamycin phosphate
SUPPOSITORY;VAGINAL 050767 NDA U.S. Pharmaceuticals 63539-011 63539-011-01 1 BLISTER PACK in 1 CARTON (63539-011-01) > 3 SUPPOSITORY in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUPPOSITORY;VAGINALStrength100MG
Approval Date:Aug 13, 1999TE:RLD:Yes
Patent:► SubscribePatent Expiration:Jul 20, 2020Product Flag?YSubstance Flag?Delist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
UBS
Mallinckrodt
US Department of Justice
McKesson
Queensland Health
Medtronic
Daiichi Sankyo
Novartis
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot